• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Elective induction of labour may improve outcomes and reduce labour-related complications

byDavy LauandAlex Chan
June 14, 2023
in Obstetrics, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Elective induction of labour at 39 weeks gestation compared to expectant management was associated with reduced likelihood of 3rd and 4th degree perineal injury, operative vaginal birth, macrosomia, and low APGAR score at 5 minutes.

2. For multiparous women, elective induction was associated with a reduced likelihood of emergency Cesarean section.

3. For nulliparous women, elective induction was associated with an increased likelihood of shoulder dystocia.

Evidence Rating Level: 2 (Good)

Study Rundown: Elective induction of labour refers to induction without a medical indication. Such indications could be maternal or neonatal, including 41 weeks gestation, pre-eclampsia, prelabour rupture of membranes, or poor fetal growth. Although elective induction of labour is associated with higher rates of C-section and adverse outcomes compared to spontaneous labour, the ARRIVE Trial found lower C-section rates and improved neonatal outcomes when comparing elective induction at 39 weeks to expectant management, meaning that labour is induced only when medically indicated. Therefore, this systematic review and meta-analysis aimed to compare neonatal outcomes and complications from labour, between 39-week elective induction and expectant management. The study also aimed to include populations who have previously been excluded from such studies, including women with high BMI and patients attempting vaginal birth after a prior C-section. This review screened observational studies and randomized controlled trials; however, most of the studies ultimately included were retrospective cohorts. Overall, the review found that compared to expectant management, 39-week elective induction was associated with reduced odds of 3rd or 4th degree perineal injury, macrosomia, operative vaginal birth, and low APGAR score at 5 minutes. For multiparous women, there was also a reduced odds of C-section. For nulliparous women, there was an increased odds of shoulder dystocia. Overall, this review generally demonstrated reduced likelihood of labour-related complications and poor neonatal outcomes with 39-week elective induction of labour compared to expectant management.

Click here to read the study in JAMA Network Open

RELATED REPORTS

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

Fetal cerebrovascular response to maternal hyperoxia testing may help predict neurodevelopmental outcomes

2 Minute Medicine Rewind July 21, 2025

Relevant Reading: Labour induction versus expectant management in low-risk nulliparous women

In-Depth [systematic review and meta-anlaysis]: This review ultimately analyzed 14 eligible studies, including 1 randomized controlled trial, 1 cross-sectional study, and 12 retrospective cohort studies. Altogether, these studies included 1,625,899 women with a singleton pregnancy, 86,555 of underwent induction at 39 weeks. The results showed that compared to expectant management, patients had 37% lower odds of 3rd or 4th degree perineal injury (OR 0.63, 95% CI 0.49-0.81), 13% lower odds of operative vaginal birth (OR 0.87, 95% CI 0.79-0.97), 34% lower odds of macrosomia (OR 0.66, 95% CI 0.48-0.91), and 38% lower odds of low 5-minute APGAR score (OR 0.62, 95% CI 0.40-0.96). For nulliparous women, there were also reductions for postpartum hemorrhage (OR 0.89, 95% CI 0.77-1.02) and emergency C-section (OR 0.75, 95% CI 0.53-1.07) that were nonsignificant. For multiparous women, there was also a 39% lower odds of emergency C-section (OR 0.61, 95% CI 0.38-0.98). And finally, for nulliparous women, there was an increased odds of shoulder dystocia (OR 1.22, 95% CI 1.02-1.46). Overall, this review generally demonstrated reduced likelihood of labour-related complications and poor neonatal outcomes with 39-week elective induction of labour compared to expectant management.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: induction of labourmaternal fetal medicineobstetrics
Previous Post

#VisualAbstract: Cilta-cel or Standard Care in Lenalidomide Refractory Multiple Myeloma

Next Post

#VisualAbstract: Bariatric metabolic surgery more effective than medical therapy and lifestyle modifications for non-alcoholic steatohepatitis

RelatedReports

Few high school students, young adults get HIV testing
Chronic Disease

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

August 22, 2025
Neurology

Fetal cerebrovascular response to maternal hyperoxia testing may help predict neurodevelopmental outcomes

July 23, 2025
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Weekly Rewinds

2 Minute Medicine Rewind July 21, 2025

July 21, 2025
Late gestation antidepressant use linked to postpartum hemorrhage
Obstetrics

Early induction of labour reduces shoulder dystocia rates in large for gestational age fetuses

June 11, 2025
Next Post
#VisualAbstract: Bariatric metabolic surgery more effective than medical therapy and lifestyle modifications for non-alcoholic steatohepatitis

#VisualAbstract: Bariatric metabolic surgery more effective than medical therapy and lifestyle modifications for non-alcoholic steatohepatitis

Single-cycle adjuvant chemotherapy may be effective in stage I testicular cancer

Pembrolizumab plus gemcitabine and cisplatin improves survival in advanced biliary tract cancer

SARS-CoV-2 infection may increase risk of prediabetes progression into diabetes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Novo’s self replicating RNA push expands cardiometabolic pipeline
  • Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab
  • 2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.